Trends in COVID-19 vaccination receipt and intention to vaccinate, United States, April to August, 2021

Nguyen, Kimberly H.; Nguyen, Kimchi; Geddes, Megan; Allen, Jennifer D.; Corlin, Laura

doi:10.1016/j.ajic.2021.12.022

Cited by 14 publications

(8 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although the differences in vaccination timing between groups were not statistically significant, these delays are notable because of the spread of the more-contagious Delta and Omicron variants in summer and winter 2021, respectively (36). Because a greater proportion of ILO participants had a high school education or less, our results are also consistent with evidence of vaccination disparities by social class, and with evidence that vaccination coverage increased most during spring and summer 2021 among people with lower education and income (37).…”

Section: Discussionsupporting

confidence: 86%

SARS-CoV-2 antibody prevalence among industrial livestock operation workers and nearby community residents, North Carolina, USA, 2021-2022

Gigot

Pisanic

Kruczynski

et al. 2022

Preprint

View full text Add to dashboard Cite

Industrial livestock operations (ILOs), particularly processing facilities, emerged as centers of coronavirus disease 2019 (COVID-19) outbreaks in spring 2020. Confirmed cases of COVID-19 underestimate true prevalence. To investigate prevalence of antibodies against SARS-CoV-2, we enrolled 279 participants in North Carolina from February 2021 to July 2022: 90 from households with at least one ILO worker (ILO), 97 from high-ILO intensity areas (ILO neighbors – ILON), and 92 from metropolitan areas (Metro). Participants provided a saliva swab we analyzed for SARS-CoV-2 IgG using a multiplex immunoassay. Prevalence of infection-induced IgG (positive for nucleocapsid and receptor binding domain) was higher among ILO (63%) compared to ILON (42.9%) and Metro (48.7%) participants (prevalence ratio [PR] =1.38; 95% confidence interval [CI]: 1.06, 1.80; ref. ILON and Metro combined). Prevalence of infection-induced IgG was also higher among ILO participants compared to an Atlanta healthcare worker cohort (PR=2.45, 95% CI: 1.8, 3.3) and a general population cohort in North Carolina (PRs 6.37-10.67). Infection-induced IgG prevalence increased over the study period. Participants reporting not masking in public in the past two weeks had higher infection-induced IgG prevalence (78.6%) compared to participants reporting masking (49.3%) (PR=1.59; 95% CI: 1.19, 2.13). Lower education, more people per bedroom, Hispanic/Latino ethnicity, and more contact with people outside the home were also associated with higher infection-induced IgG prevalence. Similar proportions of ILO (51.6%), ILON (48.4%), and Metro (55.4%) participants completed the COVID-19 primary vaccination series; median completion was more than four months later for ILO compared to ILON and Metro participants.

show abstract

Section: Discussionsupporting

confidence: 86%

SARS-CoV-2 antibody prevalence among industrial livestock operation workers and nearby community residents, North Carolina, USA, 2021-2022

Gigot

Pisanic

Kruczynski

et al. 2022

Preprint

View full text Add to dashboard Cite

show abstract

“…Despite increases in vaccination coverage since the beginning of the vaccination campaign ( 6 ), almost 1 in 6 adults have not been vaccinated or not been fully vaccinated, and almost one-half have not received a booster vaccine. Similar to sociodemographic characteristics for non-vaccination found in previous studies ( 4 , 6 ), lack of booster vaccination was highest among younger adults, Hispanic and NH Black adults, adults with lower educational attainment and income levels, adults with no insurance, adults with a previous COVID-19 diagnosis, and adults living in the Southern region of the U.S. Furthermore, adults who were not employed, were frontline essential workers or worked in a family business were more likely not to be vaccinated or boosted.…”

Section: Conclusion and Discussionmentioning

confidence: 99%

“…Previous studies have examined possible reasons for non-vaccination, which include concerns about safety and side effects, wanting to ‘wait to see’ if it is safe, and mistrust of vaccines or the government ( 6 ). However, most studies have utilized data prior to August 2021 and to our knowledge, none have assessed uptake of the booster dose by groups with elevated risk for COVID-19 infection.…”

Section: Introductionmentioning

confidence: 99%

Who has not been vaccinated, fully vaccinated, or boosted for COVID-19?

Nguyen¹,

Chen²,

Huang³

et al. 2022

American Journal of Infection Control

Self Cite

View full text Add to dashboard Cite

“…Despite the availability of vaccines, gaps still exist in vaccination coverage. 30 , 31 Given the risk of COVID-19 to workers and to people with whom they come into contact during work, reaching the remaining 20%-40% of unvaccinated employees is essential. Because the most commonly cited reason for not getting vaccinated among employees in our sample was a concern about side effects, employers may be in an ideal position to address this concern—by educating employees about the benefits of vaccination; informing employees about potential, nonserious temporary side effects after vaccination (eg, sore arm, fatigue); and providing information about what to do if they experience side effects.…”

Section: Discussionmentioning

confidence: 99%

Prevalence of Previous COVID-19 Infection, COVID-19 Vaccination Receipt, and Intent to Vaccinate Among the US Workforce

et al. 2022

Self Cite

View full text Add to dashboard Cite

Objective: As COVID-19 vaccines become more accessible to all people in the United States, more employees are returning to the workforce or switching to in-person work. However, limited information is available on vaccination coverage and intent among the US workforce. Methods: We used data from the US Census Bureau’s Household Pulse Survey, fielded during April 14–May 24, 2021 (N = 218 787), to examine the prevalence of previous COVID-19 infection, vaccination receipt, and intent to vaccinate by essential worker status and employment type. In addition, we analyzed factors associated with vaccination receipt and reasons for not getting vaccinated. Results: More than 15% of the US workforce had a previous diagnosis of COVID-19, and 73.6% received ≥1 dose of COVID-19 vaccine; however, 12.4% reported that they probably will not or definitely will not get vaccinated. Vaccination coverage (range, 63.8%-78.3%) was lowest and non-intent to get vaccinated (12.9%-21.7%) was highest among self-employed adults across all essential and nonessential worker groups. Factors associated with receipt of vaccination were age, race, Hispanic ethnicity, educational attainment, annual household income, health insurance status, and previous COVID-19 diagnosis. The main reasons for not getting vaccinated were concerns about possible side effects and waiting and seeing if the vaccine is safe. Conclusion: Identifying and addressing disparities in COVID-19 vaccination coverage in the US workforce can protect groups with low vaccine coverage and increase understanding of reasons for vaccine hesitancy. Educating employees about the vaccine and its potential side effects, promoting a culture of health and safety in the workplace, and building social norms around vaccination can help create a safe work environment for all employees and their families.

show abstract

Trends in COVID-19 vaccination receipt and intention to vaccinate, United States, April to August, 2021

Cited by 14 publications

References 3 publications

SARS-CoV-2 antibody prevalence among industrial livestock operation workers and nearby community residents, North Carolina, USA, 2021-2022

SARS-CoV-2 antibody prevalence among industrial livestock operation workers and nearby community residents, North Carolina, USA, 2021-2022

Who has not been vaccinated, fully vaccinated, or boosted for COVID-19?

Prevalence of Previous COVID-19 Infection, COVID-19 Vaccination Receipt, and Intent to Vaccinate Among the US Workforce

Contact Info

Product

Resources

About